ADC Therapeutics ADCT
NYSE ADCT
$1.59 +0.09 (+6.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

ADC Therapeutics (ADCT) Return on Equity [ROE] (2021 - 2023)

Updated

ADC Therapeutics' Return on Equity [ROE] was -4155.58% in Q2 2023, down 4021.08 percentage points from -134.50% a year earlier and down 3787.44 percentage points from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Return on Equity [ROE] (2021 - 2023) Analysis & Trends

For FY2022, Return on Equity [ROE] at ADC Therapeutics came in at -133.46%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,139.57 Bn 1,108.15 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 634.50 Bn 554.36 Bn 17.30 Bn 19.33%
3 AbbVie 500.91 Bn 474.02 Bn 12.70 Bn -
4 Merck 355.88 Bn 310.26 Bn 12.21 Bn 7.21%
5 Novartis Ag 300.26 Bn 264.25 Bn 11.24 Bn 31.52%
6 Astrazeneca 263.05 Bn 236.74 Bn 12.86 Bn 21.39%
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.00 Bn 168.19 Bn 6.22 Bn -18.38%
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn 4.97%
10 ADC Therapeutics 230.20 Mn -715.99 Mn 16.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -4,155.58%
Mar 31, 2023 -368.15%
Jun 30, 2022 -134.50%
Mar 31, 2022 -123.25%
Jun 30, 2021 -73.95%
API Access

ADC Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY